baber/WOPTO huggingface dataset:
Patent PT-1684606-E (PT)
Title: Fast applicable hair piece provided with a weaving band completely integrated with basic hair and method for attaching thereof
Inventor: GULIKER RICHARD
IPC: A41G5/00
Filed: 2004-11-08
Abstract: The invention relates to a fast applicable hair piece (1) for obtaining a special esthetical effect like e.g. a colour effect or a hair volume effect having a remarkable high wearing comfort for the user. The hair piece (1) comprises at least one thin, broad and flat hair piece (3) consisting of a number of hairs (20). The hair bundle (3, 3′, 3″) is provided at its free end with a lightweight and thin elongated weaving band (2, 2′, 2″) made from hair or from another suitable material like e.g. cotton or a synthetic material comprising regularly weaving elements (11). This weaving band is characterized by connection opening (4, 4′, 4″, 31) provided at regular mutual distance. A suitable number of basic hairs (9, 9′, 9″) may be passed through said connection openings (4, 4′, 4″, 31). As a result a temporarily, durable however eventually easily removable connection between the hair (1) piece and the basic hair (6) will be formed, in such a way that the hair piece (1) is always reusable. Furthermore the invention relates to a method for attaching a hair piece (1).
Patent PT-1576929-E (PT)
Title: Multi-layer braided structures for occluding vascular defects
Inventor: AMPLATZ KURT
IPC: A61B17/00
Filed: 2005-03-11
Abstract: A collapsible medical device and associated methods of occluding an abnormal opening in, for example, a body organ, wherein the medical device is shaped from plural layers of a heat-treatable metal fabric. Each of the fabric layers is formed from a plurality of metal strands and the assembly is heat-treated within a mold in order to substantially set a desired shape of the device. By incorporating plural layers in the thus-formed medical device, the ability of the device to rapidly occlude an abnormal opening in a body organ is significantly improved.
Patent PT-1838384-E (PT)
Title: Anti-drawback medical valve
Inventor: COTE ANDREW L SR
IPC: A61M39/04
Filed: 2005-06-10
Abstract: A medical valve has an interior flow path having a volume that is substantially the same when in either the closed mode (when the valve is closed) or the open mode (when the valve is open). To those ends, the medical valve has a housing forming an interior, and a valve mechanism (within the interior) having a substantially rigid translating member with a bore. The interior of the housing has a flow path that includes at least a portion of the bore of the translating member. As noted above, the open mode volume is substantially equal to the closed mode volume.
Patent PT-1805305-E (PT)
Title: Vehicle for the transport of a chosen molecule to a cell
Inventor: RUITERS MARCEL HERMAN JOSEF
IPC: C12N15/88
Filed: 2005-10-20
Abstract: Vehicle for the transport of a chosen molecule to a cell, comprising a SAINT-molecule which is bound to the chosen molecule by means of an electrostatic interaction, in which the SAINT-molecule is coupled to the linker molecule and the linker molecule is coupled to the cell specific ligand and in which the SAINT-molecule is covalently bound to the linker molecule.
Patent PT-2081921-E (PT)
Title: Short-acting benzodiazepine salts and their polymorphic forms
Inventor: TILBROOK GARY STUART
IPC: A61K31/55
Filed: 2007-07-10
Abstract: The invention relates to besylate salts of the compound of formula (I):Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
Patent PT-1970867-E (PT)
Title: Unitary extractor system of products for dispensing machines
Inventor: BUSTO FELIX GUINDULAIN
IPC: G07F11/42
Filed: 2008-03-13
Abstract: The product outputting system has a gear pump mounted in a central part and belt provided with toothed holes. A body is provided for supporting the products, where the products are stand to a rear side in a slightly tilted manner.
Patent PT-2207729-E (PT)
Title: Tamper evident closure
Inventor: BARDET PHILIPPE
IPC: B65D55/02
Filed: 2008-10-30
Abstract: A tamper-evident closure may include a base, a lid, and a tamper-evident member. The tamper-evident member may be irreversibly moveable between a first position in which part of the member is visible prior to initial opening of the closure and a second position in which the part is masked by the lid so as to be partly hidden from view. Upon initial opening of the closure, the tamper-evident member may be moved from the first position to the second position.
Patent PT-2450436-E (PT)
Title: Phage phi 29 dna polymerase chimera
Inventor: FALGUERAS MARGARITA SALAS
IPC: C12N9/12
Filed: 2010-07-01
Abstract: The present invention is encompassed within the biotechnology field. Specifically, it relates to a DNA polymerase chimera comprising an amino-terminal (N-terminal) region encoding a Æ29 type DNA polymerase and a carboxyl-terminal (C-terminal) region comprising at least one HhH domain which are bound by means of a connecting amino acid sequence and to the use thereof for replicating, amplifying or sequencing a template DNA. Likewise, the present invention provides a method for replicating, amplifying or sequencing a deoxyribonucleic acid with said DNA polymerase chimera and a kit for carrying out said method.
Patent PT-615754-E (PT)
Inventor: JURGEN ENGEL PROF DR
IPC: A61K47/48
Filed: 1994-03-04
Abstract: Flupirtine-containing pharmaceutical compositions with controlled release of active substance using a release-slowing component, where 0.001 to 20 parts of release-slowing component are present for one part by weight of flupirtine (as base) and the flupirtine can also be in the form of its physiologically tolerated salts, and the flupirtine release rate is between 5 and 300 mg per hour, where appropriate with the addition of a rapid-release proportion of flupirtine or one of its salts.
Patent PT-724683-E (PT)
Inventor: MAKILA ILMARI
IPC: F22D1/40
Filed: 1994-10-11
Abstract: The invention concerns an integration construction between a steam boiler and a steam turbine and a method for preheating of the supply water. In the integration construction the steam is passed from the steam boiler (10) along the duct (24a) into the steam turbine (11) so as to rotate the electric generator (12) which generates electricity. The economizer (23) consists of at least two parts, comprising at least one first economizer part (23') and at least one second economizer part (23''). The supply water is passed from the cold economizer part (23') to a supply-water preheater, which consists of a heat exchanger (24) in which thermal energy is transferred from bled steams of the steam turbine, either directly or through a medium, preferably water, into the supply water. After this, the supply water, which had been preheated by means of bled steams from the steam turbine, is passed in the steam boiler (10) into the hot economizer part (23'') and further to the vaporizer (240) and into the superheater (24) and through the superheater into the steam turbine.
Patent PT-871415-E (PT)
Inventor: COX JAMES L
IPC: A61L27/36
Filed: 1995-12-28
Abstract: This invention comprises a method of using tubular material (200) to replace a heart valve (118)(120)(162) during cardiac surgery. To create a replacement atrioventricular (mitral or tricuspid) valve (120)(160), the tube inlet is sutured to a valve annulus (121)(162) from which the native leaflets have been removed, and the tube outlet is sutured to papillary muscles (126)(128)(170) in the ventricle (112)(152). To create a semilunar (aortic or pulmonary) valve (118), the tube inlet is sutured to an annulus from which the native cusps have been removed, and the tube is either "tacked" at three points distally inside the artery, or sutured longitudinally along three lines; this allows the flaps of tissue between the three fixation points at the valve outlet to function as movable cusps. These approaches generate flow patterns that closely duplicate the flow patterns of native valves. A preferred tubular material (200) comprises submucosal tissue from the small intestine; this can be taken from the same patient who is undergoing the cardiac operation, to reduce antigenicity. Animal or cadaver intestinal tissue can also be used if properly treated, or a biocompatible synthetic tubular material can be used. This invention also discloses a properly treated intestinal tissue segment or synthetic tubular segment (500) suitable for implantation as a replacement heart valve, enclosed in a sealed sterile package (510). <IMAGE>
Patent PT-868427-E (PT)
Inventor: MUSSO GARY
IPC: C12P21/00
Filed: 1996-12-18
Abstract: Methods for identifying a compound that binds to a target are described. In general, the methods involve forming a first library comprising a multiplicity of peptides, identifying one or more peptides that bind to the target and determining a peptide motif therefrom, forming a second library comprising a multiplicity of compounds designed based on the peptide motif, selecting from the second library at least one compound that binds to the target, and determining the structure or structures of the at least one compound that binds to the target. Libraries of compounds based on a peptide motif and compounds identified by the methods of the invention are also disclosed.
Patent PT-844678-E (PT)
Inventor: BINDIG REINER
IPC: H01L41/083
Filed: 1997-11-13
Abstract: The piezoceramic actuator has a sintered stack of thin-foil piezoceramic layers alternating with inner electrode layers (3), extending inwards from opposite sides of the stack and connected in parallel via outer electrodes, provided by respective metallisations (4) applied to the contact sides of the stack, with soldered terminal elements (5). A three-dimensional structured conductive electrode (6) is provided between the metallisation and the soldered terminal element and connected to the metallisation via discrete contact points (7) between which it is expandable.
Patent PT-931543-E (PT)
Inventor: FUSCA MARTINO
IPC: A23L33/15
Filed: 1997-12-19
Abstract: The invention relates to multilayer tablets which are constructed of two, three or more layers, one layer containing probiotic microorganisms, while the other layers contain foodstuff ingredients valuable in nutritional physiology, such as vitamins, minerals, etc. The tablets are distinguished by a high stability or activity over a long period with respect to the microorganisms used and are thus very well suited for keeping in storage.
Patent PT-1007034-E (PT)
Inventor: HE KAN
IPC: A61P43/00
Filed: 1998-08-11
Abstract: Bergamottin, principle compound in grapefruit juice responsible for inhibition of p450 3a4, the predominant p450 enzyme in the intestine, is coadministered with a compound having low bioavailability to a patient to increase oral bioavailability of the compound and pharmaceutical compositions of the same, as well as a method of isolating bg from grapefruit juice.
Patent PT-1017954-E (PT)
Inventor: DANG LONG V
IPC: F01D11/00
Filed: 1998-09-09
Abstract: A heat recovery steam generator system which includes a plurality of side waterwalls defining an enclosure and a waterwall divider extending within the enclosure to define first and second chambers within the enclosure. The first chamber has an inlet and an outlet; and the second chamber has first and second inlets and an outlet, the first inlet of the second chamber is in fluid communication with the outlet of the first chamber, and a plurality of boiler bank tubes extend through the second chamber. Some forms of the invention have ducting for connecting the exhaust of an associated gas turbine partially to the inlet of the first chamber and partially to the second inlet of the second chamber. A plurality of burners may be disposed at the inlet of the first chamber and the system may also include a forced draft blower for blowing ambient air and ducting coupling the forced draft blower to the inlet of the first chamber.
Patent PT-1056978-E (PT)
Inventor: VEN LIVIEN DOMIEN
IPC: F24J2/54
Filed: 1999-02-09
Abstract: Device for heating with solar energy, which device contains at least one mirror construction (1) which is mounted on a frame (3) in a movable manner and which be directed towards the sun, and at least one collector (4) extending parallel to the mirror construction (1) in order to collect the solar radiation reflected by the mirror construction (1), characterized in that the mirror construction (1) contains a number of almost flat mirror strips (2) extending next to one another in the longitudinal direction of the collector (4) and which are each provided on the frame (3) such that they can rotate around their longitudinal direction, whereas the collector (4) is stationary in relation to the frame (3), whereby the mirror strips (2) are situated in an almost horizontal plane with their axes of rotation, whereby the device contains means (16) to rotate the mirror strips (2) and the mirroring surface of the mirror strips (2) such that the solar rays coming in on said surface can be reflected towards the collector (4).
Patent PT-1068533-E (PT)
Inventor: JUSSI HALLEEN
IPC: G01N33/573
Filed: 1999-03-30
Abstract: Tartrate-resistant acid phosphatase (TRAP) has been used as a marker from bone resorption. However, there are two forms of said enzyme in the body: TRAP 5a and TRAP 5b, of which TRAP 5b is a much more specific marker. The present invention is directed to an immunoassay for measuring the bone resorption rate, which methods enables the specific determination of TRAP 5b, whereby the amount of TRAP 5b reflects the bone resorption rate. The method is useful in diagnosing disorders associated with a change in the bone resorption rate, such as osteoporosis. Methods of screening for susceptibility to such disorders, and method of monitoring the effect of treatment are also provided. Further a test-kit useful in said methods is provided.
Patent PT-1075264-E (PT)
Inventor: TAYLOR DUNCAN PAUL
IPC: A61P25/00
Filed: 1999-04-14
Abstract: This patent application describes a new combination treatment of selective, noradrenaline-reuptake inhibitors (NARI) and specifically, reboxetine, and pindolol to provide rapid relief to patients suffering from depression, general anxiety, attention deficit hyperactivity disorder (ADHD), anxiety disorders such as obsessive compulsive disorders (OCD), panic disorders (PD), social phobia (SD) and the like.
Patent PT-1094922-E (PT)
Inventor: CRASSOUS DOMINIQUE
IPC: B63B5/08
Filed: 1999-05-07
Abstract: A planking technique for producing, in a workshop, floors of required length with straight or curved boards having planar or curved shape. The technique restricts the period for which the object is immobilized to the time during which the prefabricated panels are being glued. The technique is particularly adapted for producing the skirts of swimming pools, boat decks, saunas, thalassotherapy installations and, more particularly, floors with complex shapes. A template is produced based on the surface to be covered in a material which will be subsequently eliminated. The boards are glued with their upper surface on the template lower surface with edge bending corresponding to the bending desired for the final production. The sealant between the boards can be produced at this stage of manufacture.
Patent PT-1133896-E (PT)
Inventor: PEDERSEN JAN ABILDGAARD
IPC: H04R3/04
Filed: 1999-10-06
Abstract: It is known to make the performance of a loudspeaker “environment adaptive” in controlling a filter unit based on a measurement of the velocity/acceleration of the loudspeaker diaphragm and the associated sound pressure in front of the diaphragm, by means of an accelerometer and a microphone, respectively, thereby determining the radiation resistance of the diaphragm. The two sensors have to exhibit a constant transfer function throughout the life time of the loudspeaker, which make them very expensive. With the invention it has been found that the accelerometer can be replaced by another microphone held in a small distance from the diaphragm, and this conditions the possibility of using the same microphone for both measurements, e.g. simply by physically moving the microphone from one position to another. It will then no longer be required to use long-time stable sensors, whereby the price of the sensor equipment can be reduced dramatically. Also alternative arrangements are disclosed.
Patent SG-44489-G (SG)
Title: Parenteral formulation of nimodipin,process for its preparation and its therapeutical use
IPC: A61K31/44
Filed: 1989-07-25
Abstract: 1. Parenteral formulation containing a) 0.02 per cent by weight of dissolved nimodipine based on 100 parts by weight of a soivent consisting of b) 17-20 per cent by weight of polyethylene glycol having an average molecular weight of 200, 400 and/or 500, 20 per cent by weight of ethanol, about 50 per cent by weight of water and, optionally, small amounts of customary auxiliaries and/or additives.
Patent SG-79592-G (SG)
Title: Mixture of xanthin derivatives and o-acetyl-salicyclic acid,or their pharmacologically acceptable salts,and its use
IPC: A61K9/22
Filed: 1992-08-07
Abstract: A combination product containing (A) on the one hand a xanthine derivative of the formula    <IMAGE>  (I)  in which one of the radicals R1 and R3 represents a straight-chain alkyl, ( omega -1)-oxoalkyl or ( omega -1)-hydroxyalkyl group having 3 to 8 carbon atoms, and the two other radicals R2 and R3, or R1 and R2 represent straight-chain or branched alkyl groups having 1 to 8 carbon atoms in the position of R1 and R3 and 1 to 4 carbon atoms in the position of R2, the maximum total of carbon atoms in these two alkyl substituents being 10, or of the formula    <IMAGE> (II)  in which R represents an alkyl radical having 1 to 4 carbon atoms, or prodrug forms of the oxoalkylxanthines of the formula I and II or of the hydroxyalkylxanthine of the formula I, or its metabolites, and (B) on the other hand O-acetylsalicyclic acid or its pharmacologically tolerated salts, (C) with or without a pharmaceutical vehicle, for sequential administration in the treatment of diseases caused or characterized by impaired constituents of blood, in particular platelets or erythrocytes, but also leukocytes, in such a manner that component (A) is released first, and its use in human and veterinary medicine.
Patent IE-810103-L (IE)
Title: ¹ sulphonyl compounds
IPC: A01N43/80
Filed: 1981-01-20
Abstract: The invention relates to new sulphonyl compounds of the general formula <IMAGE> wherein X is a halogen atom, a phenoxy group, or an alkyl group or alkoxy group having 1-4 carbon atoms and substituted, if desired, with halogen; R1 is a cyano group, and R2 is an amino group which, if desired, may be substituted with halogen, with one or two alkenyl groups or alkynyl groups having 2-6 carbon atoms or with one or two alkyl groups having 1-6 carbon atoms, which alkyl groups, together with the nitrogen atom to which they are bound, may form a saturated heterocyclic ring, which ring may also contain a second hetero atom selected from the group consisting of nitrogen, oxygen and sulphur, or which alkyl groups may be substituted with an alkoxy group, having 1-4 carbon atoms, or with a dialkylamino group having 2-6 carbon atoms the alkyl groups of which, together with the nitrogen atom to which they are bound, may form a saturated heterocyclic ring; or wherein R1 and R2 together form a S,S-dialkylsulphoximido group the alkyl groups of which comprise 1-4 carbon atoms, or a 1-amino-2-azavinylene group, of which the amino group is substituted, if desired, with a cycloalkylcarbamoyl group having 4-8 carbon atoms, an alkylcarbamoyl group having 2-5 carbon atoms, a dialkylamino group the alkyl group of which comprise 1-4 carbon atoms, or an alkyl group having 1-4 carbon atoms which alkyl group may be substituted with a hydroxy group or one or more halogen atoms; or wherein R1 and R2 together form a 1-imino-2-azaethylene group of which the ring nitrogen is substituted with an alkyl group or alkenyl group having 1-4 carbon atoms, and of which the imino group may be substituted with a substituted or non-substituted phenylcarbamoyl group, having aphicidal activity. After having been processed to compositions, the compounds may be used for the control of aphids in agriculture, horticulture and forestry in a dosage from 20 to 5,000 g of active substance per hectare.
[US4379157A]
Patent IE-840263-L (IE)
Title: Integrated semiconductor circuit device for generating a¹switching control signal
IPC: G11C29/04
Filed: 1984-02-03
Abstract: An integrated semiconductor circuit device for generating a switching control signal includes a fuse having one terminal connected to a power source, and the other terminal connected to a flip-flop circuit comprising a cross-connected pair of complementary MOS field effect transistor type inverters. The output of the flip-flop circuit can be used as the switching control signal for a semiconductor memory device having a redundant circuit.
Patent IE-43706-L (IE)
Title: Haloacetophenone oximes.
IPC: A61P25/24
Filed: 1976-03-18
Abstract: The compounds of the formula <IMAGE> where Hal is Br or Cl and R is ethoxy, methoxymethyl, ethoxymethyl, cyano, methoxyethoxy or cyanomethyl when Hal is Cl and is cyano, methoxy or methoxyethoxy when Hal is Br and their salts have a strong anti-depressive activity resulting in a powerful potentiation of noradrenalin and in a strong serotonin potentiation. Monoamino oxidase inhibition does not provide a basis for the antidepressive activity of these compounds. The compounds are free from noxious side effects to a considerable extent, for example, broncho-constriction and stomach ulceration.
[US4086361A]
Patent IE-850593-L (IE)
Title: Pyrazolopyridine composition
IPC: A61K31/435
Filed: 1985-03-07
Abstract: A controlled-release pharmaceutical preparation of 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. The controlled-release preparation is in the form of rectal suppository containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. Further the controlled-release is prepared by implanting 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine in an oleaginous base.
[EP0375662A2]
Patent IE-890683-L (IE)
Title: Method for determination of a polyvalent substance using an immunoaggregate
IPC: G01N33/563
Filed: 1989-03-02
Abstract: A method for the determination of a polyvalent substance which is capable of immunological binding in the presence of at least two reactants which are specific for the substance which is capable of immunological binding, in the presence of an aggregated substance with a concentration of 0.1 to 50  mu g/ml to compensate for interfering factors in human serum samples, and a reagent suitable for this purpose.